Short answer
Expedited partner therapy bridges the hardest treatment gap, partners who will not attend clinics, by delivering medication or prescriptions without prior examination.
Proven to cut reinfection for chlamydia and gonorrhea, EPT is expressly permitted in most states for those infections (fewer cover trichomoniasis; syphilis and HIV always need in-person staged care).
At every diagnosis, ask about EPT eligibility; where it does not fit, provider referral fills the gap.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →How EPT works. The mechanics visit by visit
- Clinicians give patients treatment packs or prescriptions for named partners with written instructions, allergy and symptom screening questions, warnings, and education inserts.
- Partners take the medication as directed, read the enclosed education, and seek care for symptoms, reactions, or ongoing concerns.
- Documentation records packs dispensed (who received what for whom, with counseling noted).
EPT complements, never replaces, partner notification conversations: partners still learn of exposure, still get testing offers, still enter retesting schedules.
It removes the examination barrier, not the information one.
The legal landscape. State-by-state variation that clinicians navigate
- Expressly permitted in most states for chlamydia and gonorrhea (the core EPT indications with the strongest evidence).
- Trichomoniasis coverage varies (permitted in many, silent in others. Clinicians verify per case).
- A minority of states restrict or structure EPT differently (pharmacy rules, documentation requirements, liability shields differing).
- Laws evolve. Clinicians verify current status per case through CDC’s state-by-state legal reference rather than relying on memory.
Patients need not research statutes; asking “is EPT an option for my partners?” triggers the clinician’s verification workflow.
Notification-route context at What Is Partner Notification for STIs.
Infection boundaries. Where EPT applies and where it never does
EPT suits uncomplicated chlamydia and gonorrhea (and trichomoniasis where allowed) in asymptomatic partners.
Always in-person instead: syphilis (staging needs examinations plus titers), HIV (lifelong staged care with resistance testing), pelvic inflammatory disease (severity assessment plus parenteral options), symptomatic partners of any infection (examinations required, symptoms may signal complications or wrong diagnoses), MSM with undiagnosed HIV-risk contexts per guidance nuances, and any safety concerns (coercion, violence, provider referral protects).
Safety and documentation. The guardrails
- Allergy screening questions (penicillin, cephalosporin, macrolide histories. Alternatives where indicated).
- Advice to seek care for reactions or ongoing symptoms (printed, explicit, with clinic contacts).
- Documentation of packs dispensed (medicolegal completeness).
- Follow-up verification (index patients confirm partner treatment completion. Unconfirmed partners get provider-referral escalation, not assumptions).
When to seek care
At diagnosis (ask about EPT eligibility), for partner symptoms despite EPT (in-person escalation), and via provider referral where EPT doesn’t fit.